LLY

785.5

-1.33%↓

JNJ

151.02

-1.65%↓

ABBV

186.23

-0.54%↓

NVO

74.48

-0.29%↓

UNH

309.73

+0.41%↑

LLY

785.5

-1.33%↓

JNJ

151.02

-1.65%↓

ABBV

186.23

-0.54%↓

NVO

74.48

-0.29%↓

UNH

309.73

+0.41%↑

LLY

785.5

-1.33%↓

JNJ

151.02

-1.65%↓

ABBV

186.23

-0.54%↓

NVO

74.48

-0.29%↓

UNH

309.73

+0.41%↑

LLY

785.5

-1.33%↓

JNJ

151.02

-1.65%↓

ABBV

186.23

-0.54%↓

NVO

74.48

-0.29%↓

UNH

309.73

+0.41%↑

LLY

785.5

-1.33%↓

JNJ

151.02

-1.65%↓

ABBV

186.23

-0.54%↓

NVO

74.48

-0.29%↓

UNH

309.73

+0.41%↑

Search

Avita Therapeutics Inc

Atvērts

5.2 -4.06

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.98

Max

5.38

Galvenie mērījumi

By Trading Economics

Ienākumi

-2.3M

-14M

Pārdošana

108K

19M

EPS

-0.826

Peļņas marža

-74.857

Darbinieki

260

EBITDA

-9.9M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+177.33% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-99M

145M

Iepriekšējā atvēršanas cena

9.26

Iepriekšējā slēgšanas cena

5.2

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Avita Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. jūn. 14:44 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Orders Safran to Sell Assets to Proceed with Buy of Collins Aerospace Business

2025. g. 17. jūn. 23:43 UTC

Tirgus saruna

Nikkei May Fall Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

2025. g. 17. jūn. 23:34 UTC

Tirgus saruna

Gold Steady, Underpinned by Ongoing Geopolitical Tensions -- Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Meridian Energy Set to Draw Line Under 'Annus Horribilis' -- Market Talk

2025. g. 17. jūn. 23:17 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tourism Holdings Likely to Seek Higher Offer -- Market Talk

2025. g. 17. jūn. 23:05 UTC

Tirgus saruna

Fletcher Building Could Signal Improved Shareholder Returns -- Market Talk

2025. g. 17. jūn. 23:05 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 17. jūn. 22:58 UTC

Tirgus saruna

Australian Treasurer Chalmers Expected to Outline Second-Term Reform Agenda -- Market Talk

2025. g. 17. jūn. 22:55 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

XRG Has a Good Argument for Regulatory Approval of Santos Deal -- Market Talk

2025. g. 17. jūn. 22:31 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Lifeway Foods CEO Not Surprised by Takeover Interest -- Market Talk

2025. g. 17. jūn. 22:14 UTC

Galvenie tirgus virzītāji

Bitdeer Technologies Group Shares Fall on Note Offering

2025. g. 17. jūn. 19:49 UTC

Tirgus saruna

Natural Gas Slow Down Gains -- Market Talk

2025. g. 17. jūn. 19:34 UTC

Tirgus saruna

Oil Rises On Israel-Iran Conflict Uncertainty -- Market Talk

2025. g. 17. jūn. 19:10 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. jūn. 19:10 UTC

Tirgus saruna

Dollar Strengthens, Treasury Yields Fall in Risk-Off Trade -- Market Talk

2025. g. 17. jūn. 18:41 UTC

Tirgus saruna

Slowdown in US Consumer Spending Expected -- Market Talk

2025. g. 17. jūn. 18:15 UTC

Tirgus saruna

Gold Inches Down as Profit-Taking Seen -- Market Talk

2025. g. 17. jūn. 17:44 UTC

Tirgus saruna

Analysts Forecast Record-High Ethanol Output -- Market Talk

2025. g. 17. jūn. 16:37 UTC

Tirgus saruna

A Buy-Canadian Policy Could Support Steel Producers -- Market Talk

2025. g. 17. jūn. 16:30 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 17. jūn. 16:30 UTC

Tirgus saruna

Canada Seen Likely to Drop Digital-Services Tax -- Market Talk

2025. g. 17. jūn. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 17. jūn. 16:15 UTC

Tirgus saruna

Base Metal Prices Mixed on Risk-Off Sentiment -- Market Talk

2025. g. 17. jūn. 16:12 UTC

Tirgus saruna

Gold Futures Fall as Safe-haven Demand Retreats -- Market Talk

2025. g. 17. jūn. 14:54 UTC

Tirgus saruna

Oil Rises on Continued Israel-Iran Conflict -- Market Talk

2025. g. 17. jūn. 14:47 UTC

Tirgus saruna

European Gas Climbs on Middle East Risks, EU Russian Ban Proposal -- Market Talk

2025. g. 17. jūn. 14:41 UTC

Tirgus saruna

Natural Gas Extends Climb -- Market Talk

2025. g. 17. jūn. 14:40 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Avita Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

177.33% augšup

Prognoze 12 mēnešiem

Vidējais 15.17 USD  177.33%

Augstākais 19 USD

Zemākais 12.5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Avita Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

3

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

8.83 / 9.77Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.